Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections

Author:

Granata GuidoORCID,Petrosillo NicolaORCID,Adamoli Lucia,Bartoletti Michele,Bartoloni AlessandroORCID,Basile GregorioORCID,Bassetti Matteo,Bonfanti PaoloORCID,Borromeo Raffaella,Ceccarelli GiancarloORCID,De Luca Anna,Di Bella StefanoORCID,Fossati Sara,Franceschini EricaORCID,Gentile IvanORCID,Giacobbe DanieleORCID,Giacometti Enrica,Ingrassia Fabrizio,Lagi Filippo,Lobreglio Giambattista,Lombardi AndreaORCID,Lupo LauraORCID,Luzzati RobertoORCID,Maraolo AlbertoORCID,Mikulska Malgorzata,Mondelli Mario,Mularoni Alessandra,Mussini Cristina,Oliva AlessandraORCID,Pandolfo Alessandro,Rogati Carlotta,Trapani Filippo,Venditti MarioORCID,Viale Pierluigi,Caraffa EmanuelaORCID,Cataldo Maria,

Abstract

Background: Limited and wide-ranging data are available on the recurrent Clostridioides difficile infection (rCDI) incidence rate. Methods: We performed a cohort study with the aim to assess the incidence of and risk factors for rCDI. Adult patients with a first CDI, hospitalized in 15 Italian hospitals, were prospectively included and followed-up for 30 d after the end of antimicrobial treatment for their first CDI. A case–control study was performed to identify risk factors associated with 30-day onset rCDI. Results: Three hundred nine patients with a first CDI were included in the study; 32% of the CDI episodes (99/309) were severe/complicated; complete follow-up was available for 288 patients (19 died during the first CDI episode, and 2 were lost during follow-up). At the end of the study, the crude all-cause mortality rate was 10.7% (33 deaths/309 patients). Two hundred seventy-one patients completed the follow-up; rCDI occurred in 21% of patients (56/271) with an incidence rate of 72/10,000 patient-days. Logistic regression analysis identified exposure to cephalosporin as an independent risk factor associated with rCDI (RR: 1.7; 95% CI: 1.1–2.7, p = 0.03). Conclusion: Our study confirms the relevance of rCDI in terms of morbidity and mortality and provides a reliable estimation of its incidence.

Publisher

MDPI AG

Subject

General Medicine

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3